| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5626874 | COVIS | Controlled release pharmaceutical tablet having lenticular form |
Nov, 2014
(9 years ago) | |
Sular is owned by Covis.
Sular contains Nisoldipine.
Sular has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Sular are:
- US5626874
Sular was authorised for market use on 02 January, 2008.
Sular is available in tablet, extended release;oral dosage forms.
The generics of Sular are possible to be released after 30 November, 2014.
Drugs and Companies using NISOLDIPINE ingredient
Market Authorisation Date: 02 January, 2008
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of SULAR before it's drug patent expiration?
More Information on Dosage
SULAR family patents
